Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire

Soichiro Ogawa,1 Akihisa Hasegawa,1 Shunta Makabe,1 Akifumi Onagi,1 Kanako Matsuoka,1 Emina Kayama,1 Tomoyuki Koguchi,1 Junya Hata,1 Yuichi Sato,1 Hidenori Akaihata,1 Masao Kataoka,1 Nobuhiro Haga,2 Yoshiyuki Kojima1 1Department of Urology, Fukushima Medical University School of Medicine, Fukushima,...

Full description

Bibliographic Details
Main Authors: Ogawa S, Hasegawa A, Makabe S, Onagi A, Matsuoka K, Kayama E, Koguchi T, Hata J, Sato Y, Akaihata H, Kataoka M, Haga N, Kojima Y
Format: Article
Language:English
Published: Dove Medical Press 2022-02-01
Series:Research and Reports in Urology
Subjects:
Online Access:https://www.dovepress.com/impacts-of-neoadjuvant-hormonal-therapy-prior-to-robot-assisted-radica-peer-reviewed-fulltext-article-RRU
_version_ 1819281044552024064
author Ogawa S
Hasegawa A
Makabe S
Onagi A
Matsuoka K
Kayama E
Koguchi T
Hata J
Sato Y
Akaihata H
Kataoka M
Haga N
Kojima Y
author_facet Ogawa S
Hasegawa A
Makabe S
Onagi A
Matsuoka K
Kayama E
Koguchi T
Hata J
Sato Y
Akaihata H
Kataoka M
Haga N
Kojima Y
author_sort Ogawa S
collection DOAJ
description Soichiro Ogawa,1 Akihisa Hasegawa,1 Shunta Makabe,1 Akifumi Onagi,1 Kanako Matsuoka,1 Emina Kayama,1 Tomoyuki Koguchi,1 Junya Hata,1 Yuichi Sato,1 Hidenori Akaihata,1 Masao Kataoka,1 Nobuhiro Haga,2 Yoshiyuki Kojima1 1Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan; 2Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, JapanCorrespondence: Soichiro Ogawa, Department of Urology, Fukushima Medical University School of Medicine, 1, Hikarigaoka, Fukushima, 960-1295, Japan, Tel +81 24 547 1316, Fax +81 24 548 3393, Email soh@fmu.ac.jpPurpose: Neoadjuvant hormonal therapy (HT) before radical prostatectomy (RP) is not recommended by current guidelines in terms of oncological outcomes. Despite this, neoadjuvant HT is sometimes conducted before RP for a small proportion of patients in clinical practice. This study evaluated the impacts of neoadjuvant HT on hormonal- and sexual-related quality of life (QOL) among patients who underwent robot-assisted RP (RARP).Materials and Methods: Participants comprised 470 patients divided into a non-neoadjuvant HT group (n = 408) and a neoadjuvant HT group (n = 62). Hormonal- and sexual-related QOL were measured using the Expanded Prostate Cancer Index Composite (EPIC) questionnaire.Results: Hormonal summary scores at 6 and 9 months, function scores before and 3, 6, and 9 months and bother score at 6 months after RARP were significantly lower in the neoadjuvant HT group than in the non-neoadjuvant HT group. Sexual function scores were decreased in the neoadjuvant HT group compared to the non-neoadjuvant HT group before and 6 months after RARP. In the neoadjuvant HT group, sexual function at 3 months after RARP was significantly worse in patients with > 5 months of neoadjuvant HT than in patients with ≤ 5 months of neoadjuvant HT. Conversely, sexual bother at 3 months after RARP was significantly worse in patients with ≤ 5 months of neoadjuvant HT than in patients with > 5 months of neoadjuvant HT.Conclusion: Vintage neoadjuvant HT prior to RARP should not be recommended due to not only oncological outcomes, but also the impacts on postoperative hormonal- and sexual-related QOL.Keywords: androgen deprivation therapy, Expanded Prostate Cancer Index Composite, quality of life, hormonal therapy, neoadjuvant, robot-assisted radical prostatectomy
first_indexed 2024-12-24T00:53:26Z
format Article
id doaj.art-87c86f500f6f4febaf8ccaa313d4f94a
institution Directory Open Access Journal
issn 2253-2447
language English
last_indexed 2024-12-24T00:53:26Z
publishDate 2022-02-01
publisher Dove Medical Press
record_format Article
series Research and Reports in Urology
spelling doaj.art-87c86f500f6f4febaf8ccaa313d4f94a2022-12-21T17:23:32ZengDove Medical PressResearch and Reports in Urology2253-24472022-02-01Volume 14394873059Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported QuestionnaireOgawa SHasegawa AMakabe SOnagi AMatsuoka KKayama EKoguchi THata JSato YAkaihata HKataoka MHaga NKojima YSoichiro Ogawa,1 Akihisa Hasegawa,1 Shunta Makabe,1 Akifumi Onagi,1 Kanako Matsuoka,1 Emina Kayama,1 Tomoyuki Koguchi,1 Junya Hata,1 Yuichi Sato,1 Hidenori Akaihata,1 Masao Kataoka,1 Nobuhiro Haga,2 Yoshiyuki Kojima1 1Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan; 2Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, JapanCorrespondence: Soichiro Ogawa, Department of Urology, Fukushima Medical University School of Medicine, 1, Hikarigaoka, Fukushima, 960-1295, Japan, Tel +81 24 547 1316, Fax +81 24 548 3393, Email soh@fmu.ac.jpPurpose: Neoadjuvant hormonal therapy (HT) before radical prostatectomy (RP) is not recommended by current guidelines in terms of oncological outcomes. Despite this, neoadjuvant HT is sometimes conducted before RP for a small proportion of patients in clinical practice. This study evaluated the impacts of neoadjuvant HT on hormonal- and sexual-related quality of life (QOL) among patients who underwent robot-assisted RP (RARP).Materials and Methods: Participants comprised 470 patients divided into a non-neoadjuvant HT group (n = 408) and a neoadjuvant HT group (n = 62). Hormonal- and sexual-related QOL were measured using the Expanded Prostate Cancer Index Composite (EPIC) questionnaire.Results: Hormonal summary scores at 6 and 9 months, function scores before and 3, 6, and 9 months and bother score at 6 months after RARP were significantly lower in the neoadjuvant HT group than in the non-neoadjuvant HT group. Sexual function scores were decreased in the neoadjuvant HT group compared to the non-neoadjuvant HT group before and 6 months after RARP. In the neoadjuvant HT group, sexual function at 3 months after RARP was significantly worse in patients with > 5 months of neoadjuvant HT than in patients with ≤ 5 months of neoadjuvant HT. Conversely, sexual bother at 3 months after RARP was significantly worse in patients with ≤ 5 months of neoadjuvant HT than in patients with > 5 months of neoadjuvant HT.Conclusion: Vintage neoadjuvant HT prior to RARP should not be recommended due to not only oncological outcomes, but also the impacts on postoperative hormonal- and sexual-related QOL.Keywords: androgen deprivation therapy, Expanded Prostate Cancer Index Composite, quality of life, hormonal therapy, neoadjuvant, robot-assisted radical prostatectomyhttps://www.dovepress.com/impacts-of-neoadjuvant-hormonal-therapy-prior-to-robot-assisted-radica-peer-reviewed-fulltext-article-RRUandrogen deprivation therapyexpanded prostate cancer index compositequality of lifehormonal therapyneoadjuvantrobot-assisted radical prostatectomy
spellingShingle Ogawa S
Hasegawa A
Makabe S
Onagi A
Matsuoka K
Kayama E
Koguchi T
Hata J
Sato Y
Akaihata H
Kataoka M
Haga N
Kojima Y
Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
Research and Reports in Urology
androgen deprivation therapy
expanded prostate cancer index composite
quality of life
hormonal therapy
neoadjuvant
robot-assisted radical prostatectomy
title Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
title_full Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
title_fullStr Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
title_full_unstemmed Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
title_short Impacts of Neoadjuvant Hormonal Therapy Prior to Robot-Assisted Radical Prostatectomy on Postoperative Hormonal- and Sexual-Related Quality of Life – Assessment by Patient-Reported Questionnaire
title_sort impacts of neoadjuvant hormonal therapy prior to robot assisted radical prostatectomy on postoperative hormonal and sexual related quality of life ndash assessment by patient reported questionnaire
topic androgen deprivation therapy
expanded prostate cancer index composite
quality of life
hormonal therapy
neoadjuvant
robot-assisted radical prostatectomy
url https://www.dovepress.com/impacts-of-neoadjuvant-hormonal-therapy-prior-to-robot-assisted-radica-peer-reviewed-fulltext-article-RRU
work_keys_str_mv AT ogawas impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT hasegawaa impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT makabes impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT onagia impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT matsuokak impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT kayamae impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT koguchit impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT hataj impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT satoy impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT akaihatah impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT kataokam impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT hagan impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire
AT kojimay impactsofneoadjuvanthormonaltherapypriortorobotassistedradicalprostatectomyonpostoperativehormonalandsexualrelatedqualityoflifendashassessmentbypatientreportedquestionnaire